Immunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations.

Owens E, Chandar MS, Khasraw M

Open source

DOI
10.1097/wco.0000000000001524
Published
2026 Dec 1
Container
Current opinion in neurology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/wco.0000000000001524,
  title = {Immunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations.},
  author = {Owens E and Chandar MS and Khasraw M},
  year = {2026},
  journal = {Current opinion in neurology},
  doi = {10.1097/wco.0000000000001524},
  url = {https://doi.org/10.1097/wco.0000000000001524}
}

RIS

TY  - JOUR
TI  - Immunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations.
AU  - Owens E
AU  - Chandar MS
AU  - Khasraw M
PY  - 2026
JO  - Current opinion in neurology
DO  - 10.1097/wco.0000000000001524
UR  - https://doi.org/10.1097/wco.0000000000001524
ER  - 

APA

E, O., MS, C., & M, K. (2026). Immunotherapy for gliomas: from checkpoint blockade to vaccines, cellular therapy, local immune engineering and combinations.. Current opinion in neurology. https://doi.org/10.1097/wco.0000000000001524

Source records